Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441028 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
Endothelial activation and upregulation of procoagulant activity seem important mechanisms involved in early (B)EP-chemotherapy-induced vascular events. Before chemotherapy, a quarter already had cardiovascular risk factors. A vascular fingerprint could identify patients at risk for arterial events. This vascular fingerprint, when validated, can be used as a tool to select patients who may benefit from preventive strategies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S. Lubberts, H. Boer, R. Altena, C. Meijer, A.M. van Roon, N. Zwart, S.F. Oosting, P.W. Kamphuisen, J. Nuver, A.J. Smit, A.B. Mulder, J.D. Lefrandt, J.A. Gietema,